These top venture capitalists don’t wait for biotech startups to come to them. They create companies themselves.
The path to greatness in biotechnology runs through a vale of tears. Mark Levin wants to remember that.
These top venture capitalists don’t wait for biotech startups to come to them. They create companies themselves.
The path to greatness in biotechnology runs through a vale of tears. Mark Levin wants to remember that.